Paper8044938
Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.
Tomai F and 7 others. Circulation, 1994. Cited by 400 papers, by iCite.
Cite this record
ConductScience Library. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Papers, record 8044938. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8044938
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Triphosphate | Major topic |
| Angioplasty, Balloon, Coronary | Major topic |
| Calcium Channel Blockers | Major topic |
| Calcium Channels | Major topic |
| Glyburide | Major topic |
| Myocardial Ischemia | Major topic |
| Blood Glucose | |
| Coronary Circulation | |
| Electrocardiography | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Monitoring, Physiologic | |
| Single-Blind Method |
Source PubMed
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 400 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38918852 | The causal relationship between anti-diabetic drugs and gastrointestinal disorders: a drug-targeted mendelian randomization study. | Diabetol Metab Syndr | 2024 | https://conductscience.org/library/papers/38918852 | PubMed |
| 38234711 | Adenosine Receptor Subtypes and Cardioprotection. | Drug Dev Res | 1998 | https://conductscience.org/library/papers/38234711 | PubMed |
| 38226326 | Validation of Blood Glucose and Lipid-Lowering Effect of Solvent Fractions of the Crinum Abyssinicum Shoot Tips in Streptozotocin-Induced Diabetic Mice. | Glob Adv Integr Med Health | 2024 | https://conductscience.org/library/papers/38226326 | PubMed |
| 38028722 | Sevoflurane-mediated modulation of oxidative myocardial injury. | J Cardiovasc Thorac Res | 2023 | https://conductscience.org/library/papers/38028722 | PubMed |
| 36592075 | Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery - A Meta-Analysis. | Braz J Cardiovasc Surg | 2023 | https://conductscience.org/library/papers/36592075 | PubMed |
| 35136357 | Evaluation of Anti-Diabetic and Anti-Hyperlipidemic Activities of Hydro-Alcoholic Crude Extract of the Shoot Tips of Crinum abyssinicum Hochst. ex A. Rich (Amaryllidaceae) in Mice. | J Exp Pharmacol | 2022 | https://conductscience.org/library/papers/35136357 | PubMed |
| 33116953 | Hypoglycemic, Anti-Hyperglycemic and Anti-Hyperlipidemic Effects of Bersama abyssinica Fresen (Melianthaceae) Leaves' Solvent Fractions in Normoglycemic and Streptozotocin-Induced Diabetic Mice. | J Exp Pharmacol | 2020 | https://conductscience.org/library/papers/33116953 | PubMed |
| 32620851 | Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. | Nat Rev Cardiol | 2020 | https://conductscience.org/library/papers/32620851 | PubMed |
| 32607006 | Evaluation of in vitro and in vivo Anti-Diabetic, Anti-Hyperlipidemic and Anti-Oxidant Activity of Flower Crude Extract and Solvent Fractions of Hagenia Abyssinica (Rosaceae). | J Exp Pharmacol | 2020 | https://conductscience.org/library/papers/32607006 | PubMed |
| 31276600 | Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study. | Br J Clin Pharmacol | 2019 | https://conductscience.org/library/papers/31276600 | PubMed |
| 30271452 | Antidiabetic Activities of Hydromethanolic Leaf Extract of Calpurnia aurea (Ait.) Benth. Subspecies aurea (Fabaceae) in Mice. | Evid Based Complement Alternat Med | 2018 | https://conductscience.org/library/papers/30271452 | PubMed |
| 29795806 | Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes. | Cond Med | 2018 | https://conductscience.org/library/papers/29795806 | PubMed |
| 29788955 | Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes. | Cardiovasc Diabetol | 2018 | https://conductscience.org/library/papers/29788955 | PubMed |
| 28594895 | ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway. | PLoS One | 2017 | https://conductscience.org/library/papers/28594895 | PubMed |
| 28545784 | Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence. | Trends Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28545784 | PubMed |
| 27431258 | Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies. | Cardiovasc Diabetol | 2016 | https://conductscience.org/library/papers/27431258 | PubMed |
| 27268470 | Cardiovascular effects of anti-diabetes drugs. | Expert Opin Drug Saf | 2016 | https://conductscience.org/library/papers/27268470 | PubMed |
| 26535899 | Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems. | PLoS One | 2015 | https://conductscience.org/library/papers/26535899 | PubMed |
| 26287407 | Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease. | Medicine (Baltimore) | 2015 | https://conductscience.org/library/papers/26287407 | PubMed |
| 25205223 | Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study. | Diabetologia | 2015 | https://conductscience.org/library/papers/25205223 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8044938
GET https://conductscience.org/api/papers/v1/8044938/cited_by?page=2